EGBN vs EW · rev $258.5M vs P/E 47, rev $3.39B
Eagle Bancorp Inc (EGBN) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Eagle Bancorp Inc (EGBN) is a banks - regional company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported EGBN revenue for 2026-06-30 was $258.5M. Net income was $21.6M. Revenue was up 96.0% from 2026-03-31 to 2026-06-30. EGBN currently screens at market cap $788.3M.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
EGBN currently screens at market cap $788.3M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the EGBN and EW stock pages for the full models.
Not investment advice.